IRVINE, Calif., Feb. 15, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that Praxsyn’s corporate headquarters have been moved from Irvine, California to Las Vegas, Nevada.
The board of directors authorized the move of Praxsyn Corporation’s headquarters to Nevada in order to allow for the expansion of Praxsyn’s operations, the ability to secure a larger pharmacy facility in Nevada at a more competitive price, and the overall lower labor costs.
Greg Sundem, PXYN’s Chief Executive Officer, stated “I have moved to Nevada from California because I believe it is important to be physically at any new facility to oversee the day-to-day operations and to ensure a successful transition.”
The new facility provides ample space for collection operations; with our increased focus on products and services that will pay within a 30-day billing cycle. By changing the business model to a type of business that collects in a shorter amount of time, the company will have a more fiscally responsible financial model than the long collection cycle.
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients. Mesa Pharmacy, located in Irvine, California works to realize the vision of medical professionals to improve the lives of their patients. Mesa Pharmacy continues its operations and services in Irvine, California to provide patients with pharmaceutical treatments as prescribed by their doctors. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Praxsyn Corporation’s move to Las Vegas, Nevada, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
###
Media/Investor Contact: [email protected] 949-777-6112 ext 101


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



